612 related articles for article (PubMed ID: 35189826)
1. High procalcitonin levels associated with increased intensive care unit admission and mortality in patients with a COVID-19 infection in the emergency department.
Tong-Minh K; van der Does Y; Engelen S; de Jong E; Ramakers C; Gommers D; van Gorp E; Endeman H
BMC Infect Dis; 2022 Feb; 22(1):165. PubMed ID: 35189826
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic yield of bacteriological tests and predictors of severe outcome in adult patients with COVID-19 presenting to the emergency department.
Kaal A; Snel L; Dane M; van Burgel N; Ottens T; Broekman W; El Bouazzaoui L; Kolfschoten N; Schippers E; Steyerberg E; Meziyerh S; van Nieuwkoop C
Emerg Med J; 2021 Sep; 38(9):685-691. PubMed ID: 34289966
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19.
Pink I; Raupach D; Fuge J; Vonberg RP; Hoeper MM; Welte T; Rademacher J
Infection; 2021 Oct; 49(5):935-943. PubMed ID: 34021897
[TBL] [Abstract][Full Text] [Related]
4. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.
Dolci A; Robbiano C; Aloisio E; Chibireva M; Serafini L; Falvella FS; Pasqualetti S; Panteghini M
Clin Chem Lab Med; 2020 Nov; 59(2):433-440. PubMed ID: 33554505
[TBL] [Abstract][Full Text] [Related]
5. Are admission procalcitonin levels universal mortality predictors across different medical emergency patient populations? Results from the multi-national, prospective, observational TRIAGE study.
Sager R; Wirz Y; Amin D; Amin A; Hausfater P; Huber A; Haubitz S; Kutz A; Mueller B; Schuetz P
Clin Chem Lab Med; 2017 Oct; 55(12):1873-1880. PubMed ID: 28412721
[TBL] [Abstract][Full Text] [Related]
6. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients.
Galli F; Bindo F; Motos A; Fernández-Barat L; Barbeta E; Gabarrús A; Ceccato A; Bermejo-Martin JF; Ferrer R; Riera J; Peñuelas O; Lorente JÁ; de Gonzalo-Calvo D; Menéndez R; Gonzalez J; Misuraca S; Palomeque A; Amaya-Villar R; Añón JM; Balan Mariño A; Barberà C; Barberán J; Blandino Ortiz A; Bustamante-Munguira E; Caballero J; Cantón-Bulnes ML; Carbajales Pérez C; Carbonell N; Catalán-González M; de Frutos R; Franco N; Galbán C; Lopez Lago A; Gumucio-Sanguino VD; de la Torre MDC; Díaz E; Estella Á; Gallego Curto E; García-Garmendia JL; Gómez JM; Huerta A; Jorge García RN; Loza-Vázquez A; Marin-Corral J; Martin Delgado MC; Martínez de la Gándara A; Martínez Varela I; Lopez Messa J; M Albaiceta G; Nieto MT; Novo MA; Peñasco Y; Pérez-García F; Pozo-Laderas JC; Ricart P; Sagredo V; Sánchez-Miralles A; Sancho Chinesta S; Roche-Campo F; Socias L; Solé-Violan J; Suarez-Sipmann F; Tamayo Lomas L; Trenado J; Úbeda A; Valdivia LJ; Vidal P; Boado MV; Rodríguez A; Antonelli M; Blasi F; Barbé F; Torres A;
Intensive Care Med; 2023 Aug; 49(8):934-945. PubMed ID: 37507573
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin concentration in the emergency department predicts 30-day mortality in COVID-19 better than the lymphocyte count, the neutrophil-tolymphocyte ratio, or the C-reactive protein level.
López-Ayala P; Alcaraz-Serna A; Valls Carbó A; Cuadrado Cenzual MÁ; Torrejón Martínez MJ; López Picado A; Martínez Valero C; Miranda JD; Díaz Del Arco C; Cozar López G; Suárez-Cadenas MDM; Jerez Fernández P; Angós B; Rodríguez Adrada E; Cardassay E; Del Toro E; Chaparro D; Montalvo Moraleda MT; Espejo Paeres C; García Briñón MÁ; Hernández Martín-Romo V; Ortega L; Fernández Pérez C; Martínez-Novillo M; González Armengol JJ; González Del Castillo J; Mueller CE; Martín-Sánchez FJ;
Emergencias; 2022 Apr; 34(2):119-127. PubMed ID: 35275462
[TBL] [Abstract][Full Text] [Related]
8. A cytokine panel and procalcitonin in COVID-19, a comparison between intensive care and non-intensive care patients.
Mazaheri T; Ranasinghe R; Al-Hasani W; Luxton J; Kearney J; Manning A; Dimitriadis GK; Mare T; Vincent RP
PLoS One; 2022; 17(5):e0266652. PubMed ID: 35500008
[TBL] [Abstract][Full Text] [Related]
9. Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients.
Carbonell R; Urgelés S; Salgado M; Rodríguez A; Reyes LF; Fuentes YV; Serrano CC; Caceres EL; Bodí M; Martín-Loeches I; Solé-Violán J; Díaz E; Gómez J; Trefler S; Vallverdú M; Murcia J; Albaya A; Loza A; Socias L; Ballesteros JC; Papiol E; Viña L; Sancho S; Nieto M; Del M; Lorente C; Badallo O; Fraile V; Arméstar F; Estella A; Abanses P; Sancho I; Guasch N; Moreno G;
J Infect; 2022 Oct; 85(4):374-381. PubMed ID: 35781017
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis.
Huang I; Pranata R; Lim MA; Oehadian A; Alisjahbana B
Ther Adv Respir Dis; 2020; 14():1753466620937175. PubMed ID: 32615866
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study).
van der Does Y; Limper M; Jie KE; Schuit SCE; Jansen H; Pernot N; van Rosmalen J; Poley MJ; Ramakers C; Patka P; van Gorp ECM; Rood PPM
Clin Microbiol Infect; 2018 Dec; 24(12):1282-1289. PubMed ID: 29870855
[TBL] [Abstract][Full Text] [Related]
12. Lack of admission biomarkers' clinical utility in outcomes prediction in patients suspected with infection in the emergency department.
Gornet M; Leroux P; Ramont L; De Ruffi S; Giordano Orsini G; Losset X; Kanagaratnam L; Gennai S
Am J Emerg Med; 2021 Sep; 47():109-114. PubMed ID: 33799140
[TBL] [Abstract][Full Text] [Related]
13. The predictive and prognostic role of hematologic and biochemical parameters in the emergency department among coronavirus disease 2019 patients.
Huang CY; Tsai HW; Liu CY; Liu TH; Huang HL; Chang CC; Chen WC; Sun JT
Chin J Physiol; 2021; 64(6):306-311. PubMed ID: 34975124
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission.
Gonzalez Del Castillo J; Wilson DC; Clemente-Callejo C; Román F; Bardés-Robles I; Jiménez I; Orviz E; Dastis-Arias M; Espinosa B; Tornero-Romero F; Giol-Amich J; González V; Llopis-Roca F;
Crit Care; 2019 Oct; 23(1):335. PubMed ID: 31665092
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of procalcitonin in hospitalized COVID-19 patients and clinical outcomes of antibiotic use stratified by procalcitonin levels.
So W; Simon MS; Choi JJ; Wang TZ; Williams SC; Chua J; Kubin CJ
Intern Emerg Med; 2022 Aug; 17(5):1405-1412. PubMed ID: 35277828
[TBL] [Abstract][Full Text] [Related]
17. Combination of procalcitonin and C-reactive protein levels in the early diagnosis of bacterial co-infections in children with H1N1 influenza.
Li Z; He L; Li S; He W; Zha C; Ou W; Hou Q; Wang W; Sun X; Liang H
Influenza Other Respir Viruses; 2019 Mar; 13(2):184-190. PubMed ID: 30443990
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of procalcitonin in cancer patients with coronavirus disease 2019.
Tiutan T; Wallins JS; Brown S; Gonen M; Korenstein D
Clin Chem Lab Med; 2023 Jan; 61(2):339-348. PubMed ID: 36367353
[TBL] [Abstract][Full Text] [Related]
19. [Predictive value of postoperative serum procalcitonin concentration for moderate to severe acute respiratory distress syndrome in patients undergoing cardiopulmonary bypass surgery].
Li M; Chen H; Yu R
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 May; 35(5):487-492. PubMed ID: 37308228
[TBL] [Abstract][Full Text] [Related]
20. Higher diagnostic accuracy and cost-effectiveness using procalcitonin in the treatment of emergency medicine patients with fever (The HiTEMP study): a multicenter randomized study.
van der Does Y; Limper M; Schuit SC; Poley MJ; van Rosmalen J; Ramakers C; Patka P; van Gorp EC; Rood PP
BMC Emerg Med; 2016 Apr; 16():17. PubMed ID: 27048405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
